Ms. Lana Culley reports

AURORA ADVANCES GLOBAL MEDICAL CANNABIS PORTFOLIO WITH NEW PRODUCT LAUNCHES ACROSS KEY INTERNATIONAL MARKETS

Aurora Cannabis Inc. is significantly expanding its global medical cannabis portfolio, with new product launches rolling out across Canada, Europe and Australia. The company continues to shape the global cannabis landscape by introducing new products and formats around the world. The newly expanded lineup includes dried flower, prerolls and pastilles, reflecting Aurora's long-standing focus on innovation, quality and patient choice while driving sustainable growth internationally.

"As our global medical business continues to grow, our focus remains on delivering consistency and reliability across the markets we serve," said Lana Culley, vice-president, innovation and international operations, at Aurora. "By expanding our offerings in key countries, we're responding to clear patient and prescriber demand with products that meet local regulatory standards, offer meaningful choice across formats and can be supplied reliably at scale -- all while reinforcing the level of quality and trust expected from us."

The new products align with Aurora's medical-first strategy and leverage the company's global GMP-certified (good manufacturing practice) manufacturing network.

Aurora's expanded medical cannabis offerings will roll out in their respective markets between now and June; new product launches include:

Germany -- a broader portfolio of medical cannabis options:

• San Raf -- Pink OG Kush (indica, dried flower, THC (tetrahydrocannabinol) 25 to 27 per cent, CBD (cannabidiol) less than 1.0 per cent): This cultivar has a spicy and sweet aroma profile of lemon, lavender and spice and is bred from OG Kush.
• Daily Special -- Lemon Sorbet (sativa, dried flower, THC 21 per cent, CBD less than 1.0 per cent): This cultivar has an aroma profile of spice, wood and lemon and is bred from Gelonade X Biscotti.

Poland -- expanded potency range across existing offerings:

• Cannabis flos Aurora -- Electric Honeydew (hybrid, dried flower, THC 27 per cent, CBD less than or equal to 1.0 per cent): This cultivar has an aroma profile of melon, gas and pine and is bred from Girl Scout Cookies x 91 OG Krypt Melon.
• Cannabis flos Aurora -- Chemango Kush (indica, dried flower, THC 29 per cent, CBD less than or equal to 1.0 per cent): This cultivar has an aroma profile of fruity, sour and chem and is bred from OG Kush x Wedding Cake x GMO x Fuel.

Australia -- featuring pastilles, an edible format that is discreet, precisely dosed and long lasting:

• Aurora -- Black Raspberry Pastilles: 60-pack, THC 20 milligrams, CBD 20 mg, CBN (cannabinol) 30 mg;
• Aurora -- Blood Orange Pastilles: 60-pack, THC 32 mg, CBD 32 mg, CBG (cannabigerol) 32mg and CBC (cannabichromene) 10 mg.

Canada -- medical portfolio growth in core formats:

• WMMC -- Seasonal Stash Dank Matter (sativa, dried flower, 28 grams, THC 24 to 30 per cent): This cultivar has an aroma profile of gas, licorice and vanilla and is bred from Banana Puddintain x White Mac.
• WMMC -- Seasonal Stash Custard Kush (indica, dried flower, 28 g, THC 25 to 31 per cent): This cultivar has an aroma profile of creamy, berry and oak and is bred from La Bomba x White Mac.
• San Raf -- Melon Mouth (hybrid, preroll, seven 0.5-gram pieces, THC 22 to 28 per cent): This cultivar has an aroma profile of fruity, sweet and diesel and is bred from Girl Scout Cookies x Chem 91 x Crypt OG.
• San Raf -- Stink Biscuit (indica, dried flower, 3.5 g, THC 22 to 28 per cent): This cultivar has an aroma profile of gas, funk and sourdough and is bred from GMO x Animal Cookies.

Together, these launches reflect Aurora's continued role in advancing regulated medical cannabis globally, supporting the growth of these markets with high-quality products, diverse formats and reliable supply.

About Aurora Cannabis Inc.

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance and a deep commitment to patient care. Aurora serves both medical and consumer markets across Canada, Europe, Australia and New Zealand, with a strategic focus on high-margin opportunities and a medical-first approach. Aurora's portfolio of trusted, leading brands includes Aurora, MedReleaf, Pedanios, IndiMed, San Raf, Tasty's and Whistler Medical Marijuana Co. With world-class, GMP-certified manufacturing facilities in Canada and Germany and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of opening the world to cannabis.

Aurora's common shares trade on the Nasdaq Stock Market and Toronto Stock Exchange under the symbol ACB.

We seek Safe Harbor.